CN Patent

CN108014343A — 一种治疗乳腺癌的药物组合物及其制备方法

Assigned to Individual · Expires 2018-05-11 · 8y expired

What this patent protects

本发明涉及药物制剂领域，具体公开了一种治疗乳腺癌的药物组合物及其制备方法。本发明所述的药物组合物包括以下质量百分含量的组分：帕博西尼26％‑30％，乳糖醇38％‑40％，微晶纤维素28％‑32％，波拉克林钾1％‑3％，甲基纤维素1％‑3％。该组合物适合湿法制粒，其采用湿法制粒制得的片剂溶出度高、杂质含量低、流动性好、片重差异小、稳定性好。

USPTO Abstract

本发明涉及药物制剂领域，具体公开了一种治疗乳腺癌的药物组合物及其制备方法。本发明所述的药物组合物包括以下质量百分含量的组分：帕博西尼26％‑30％，乳糖醇38％‑40％，微晶纤维素28％‑32％，波拉克林钾1％‑3％，甲基纤维素1％‑3％。该组合物适合湿法制粒，其采用湿法制粒制得的片剂溶出度高、杂质含量低、流动性好、片重差异小、稳定性好。

Drugs covered by this patent

Patent Metadata

Patent number
CN108014343A
Jurisdiction
CN
Classification
—
Expires
2018-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.